Literature DB >> 25673913

Exposure of feral swine (Sus scrofa) in the United States to selected pathogens.

John A Baroch1, Carl A Gagnon1, Sonia Lacouture1, Marcelo Gottschalk1.   

Abstract

Feral swine (Sus scrofa) are widely distributed in the United States. In 2011 and 2012, serum samples and tonsils were recovered from 162 and 37 feral swine, respectively, in the US to evaluate exposure to important swine endemic pathogens. Antibodies against porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) were found in 2.5% and 25.3% of tested sera, respectively. Positive serological reactions against Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae have been detected in 19.7% and 69.7% of animals. More than 15% of animals presented antibodies against these 2 pathogens simultaneously. Most animals were also seropositive for Lawsonia intracellularis. Feral swine can also be involved in transmission of zoonotic agents. Almost 50% of animals possessed antibodies against Salmonella. In addition, 94.4% of animals were carriers of Streptococcus suis in their tonsils. In conclusion, feral swine may be considered as a potential reservoir for different endemic diseases in domestic pigs, as well as for important zoonotic agents.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25673913      PMCID: PMC4283238     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  28 in total

1.  Foreign animal diseases and Canadian wildlife: reasons for concern and the elements of preparedness.

Authors:  Frederick A Leighton
Journal:  Can Vet J       Date:  2002-04       Impact factor: 1.008

2.  Prevalence of Actinobacillus pleuropneumoniae infection in hunted wild boars (Sus scrofa) in Germany.

Authors:  Gerald Reiner; Christina Fresen; Sebastian Bronnert; Ingo Haack; Hermann Willems
Journal:  J Wildl Dis       Date:  2010-04       Impact factor: 1.535

3.  Evaluation of diagnostic assays for the serological detection of Actinobacillus pleuropneumoniae on samples of known or unknown exposure.

Authors:  Tanja Opriessnig; Michelle Hemann; John K Johnson; Sheila Heinen; Luis G Giménez-Lirola; Kevin C O'Neill; Hai Hoang; Kyoung-Jin Yoon; Marcelo Gottschalk; Patrick G Halbur
Journal:  J Vet Diagn Invest       Date:  2013-01-04       Impact factor: 1.279

4.  Prevalence of Streptococcus suis genotypes in wild boars of Northwestern Germany.

Authors:  Christoph G Baums; Gerd Josef Verkühlen; Thomas Rehm; Luciana M G Silva; Martin Beyerbach; Klaus Pohlmeyer; Peter Valentin-Weigand
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

Review 5.  Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.

Authors:  J D Dubreuil; M Jacques; K R Mittal; M Gottschalk
Journal:  Anim Health Res Rev       Date:  2000-12       Impact factor: 2.615

6.  Antibodies to selected viral and bacterial pathogens in European wild boars from southcentral Spain.

Authors:  Joaquín Vicente; Luís León-Vizcaíno; Christian Gortázar; María José Cubero; Mónica González; Pablo Martín-Atance
Journal:  J Wildl Dis       Date:  2002-07       Impact factor: 1.535

7.  Eucaryotic expression of the nucleocapsid protein gene of porcine circovirus type 2 and use of the protein in an indirect immunofluorescence assay for serological diagnosis of postweaning multisystemic wasting syndrome in pigs.

Authors:  Sébastien Racine; Ali Kheyar; Carl A Gagnon; Benoît Charbonneau; Serge Dea
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

8.  Multiplex PCR assay for detection of Streptococcus suis species and serotypes 2 and 1/2 in tonsils of live and dead pigs.

Authors:  C Marois; S Bougeard; M Gottschalk; M Kobisch
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Prevalence of Actinobacillus pleuropneumoniae, Actinobacillus suis, Haemophilus parasuis, Pasteurella multocida, and Streptococcus suis in representative Ontario swine herds.

Authors:  Janet I MacInnes; Marcelo Gottschalk; Abdul G Lone; Devon S Metcalf; Shivani Ojha; Thomas Rosendal; Sheila B Watson; Robert M Friendship
Journal:  Can J Vet Res       Date:  2008-04       Impact factor: 1.310

10.  Evaluation and field validation of PCR tests for detection of Actinobacillus pleuropneumoniae in subclinically infected pigs.

Authors:  Nahuel Fittipaldi; André Broes; Josée Harel; Marylène Kobisch; Marcelo Gottschalk
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

View more
  6 in total

1.  Current status and future recommendations for feral swine disease surveillance in the United States.

Authors:  Vienna R Brown; Michael C Marlow; Rachel M Maison; Thomas Gidlewski; Richard Bowen; Angela Bosco-Lauth
Journal:  J Anim Sci       Date:  2019-05-30       Impact factor: 3.159

Review 2.  Is There a Risk for Introducing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Through the Legal Importation of Pork?

Authors:  Megan C Niederwerder; Raymond R R Rowland
Journal:  Food Environ Virol       Date:  2016-09-02       Impact factor: 2.778

3.  Isolation of Biotype 1 Serotype 12 and Detection of Actinobacillus pleuropneumoniae from Wild Boars.

Authors:  Rita Sárközi; László Makrai; László Fodor
Journal:  Pathogens       Date:  2022-04-24

Review 4.  Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination.

Authors:  Emanuela Pileri; Enric Mateu
Journal:  Vet Res       Date:  2016-10-28       Impact factor: 3.683

5.  A globally-distributed alien invasive species poses risks to United States imperiled species.

Authors:  Meredith L McClure; Christopher L Burdett; Matthew L Farnsworth; Steven J Sweeney; Ryan S Miller
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

6.  Survey for selected pathogens in wild pigs (Sus scrofa) from Guam, Marianna Islands, USA.

Authors:  Christopher A Cleveland; Anthony DeNicola; J P Dubey; Dolores E Hill; Roy D Berghaus; Michael J Yabsley
Journal:  Vet Microbiol       Date:  2017-05-03       Impact factor: 3.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.